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Abstract
Background: Hepatitis delta virus (HDV) and Hepatitis B virus (HBV) co-infection is well known to induce a
spectrum of acute and chronic liver diseases which further advance to cirrhosis, fulminant hepatitis and
hepatocellular carcinoma (HCC).
Aim: The aim of the present study was to determine the prevalence of hepatitis D virus super-infection among
hepatitis B surface antigen (HBsAg) positive individuals in the highly populated province of Pakistan which is not
well known.
Methods: Sera samples were subjected to HBsAg and anti-HDV screening and finally anti-HDV and HBsAg positive
coinfected samples were used for HDV active RNA confirmation using nested polymerase chain reaction (PCR).
Results: Out of total 200 HBsAg positive samples by rapid device, 96 (48%) were also found reactive for HBsAg
using enzyme linked immunosorbant assay (ELISA). Out of these HBsAg ELISA positive samples, 80 (88.8%) were
anti-HDV ELISA positive which were then subjected to PCR. The amplification results further confirmed 24 (30%)
samples to be HDV RNA positive. HDV super-infection was more common in male patients than female patients
(81% VS 19%).
Conclusion: The current study shows a high prevalence rate of HDV-HBV co-infection in Pakistan that tends to
increase over time.
Background
More than 350 million individuals worldwide are Hepa-
titis B Virus (HBV) carriers and at least 5% of these are
co-infected with hepatitis delta virus (HDV) [1]. HDV is
a delta agent that is deformed and incomplete RNA
virus whose replication and expression is dependent on
the presence of HBsAg. HDV is considered to be a sub-
viral satellite because it can propagate only in the pre-
sence HBV [2]. In association with HBV, HDV produces
significantly more severe illness than HBV alone [3].
HDV is now well known to induce a spectrum of both
acute and chronic liver diseases [4]. Individuals having
HBV-HDV co-infection may have more severe acute
disease and higher risks of fulminant hepatitis, cirrhosis
and hepatocellular carcinoma (HCC) than those having
HBV infection alone [5,6].
Over 15 million people are infected with HDV world-
wide and its prevalence in Italy, Eastern Europe and
western region of Asia is higher than in the rest of
world and appears to be endemic in the Middle East [7].
From Pakistan few studies are available on the co-infec-
tion of HDV and HBV from other provinces. For exam-
ple Qureshi and colleagues [8] showed the effect of
Lamivudine on Sero conversion of HBeAg positive cases
co-infected with Delta hepatitis in Islamabad. Seetlani
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HBsAg (hepatitis B surface antigen) positive patient vis-
iting liver clinics in Karachi. Mumtaz et al 2005 stated
the epidemiology and clinical pattern of epatitis Delta
virus infection in Pakistan [9]. Zuberi et al 2008 deter-
mined the frequency of hepatitis C and D in patients of
chronic hepatitis B and the treatment response of hepa-
titis B in such patients [10].
No study on the dual infection of HDV and HBV is
available from Punjab, Pakistan that is the largest pro-
vince of this country. Therefore, the aim of the current
study was to estimate the co-infection of hepatitis D
virus in hepatitis B surface antigen (HBsAg) positive
patients in the largest province of Pakistan.
Methods
Sample collection
A total of 200 sera samples that were found positive for
HBV by rapid Immunoblot screening methods were
received from 2009 to 2010 that were included in this
study. A filled standard form containing subject’s demo-
graphics and risk behaviors were also received along
with each sample. Out of these, 96 samples were found
positive for hepatitis B surface antigen (HBsAg) by
Enzyme linked Immunosorbant Assay (ELISA) method
and were used for anti-HDV ELISA analysis. Out of
these, 80 anti-HDV ELISA positive samples were further
analyzed by HDV PCR. Total 56 anti-HDV ELISA posi-
tive samples were found negative for HDV RNA by
PCR. All the samples belonged to different regions of
Punjab, Pakistan. A filled standard form containing sub-
ject’s demographics and risk behaviours were also
received along with each sample.
HBsAg and Anti-HDV Screening
Initially all the patient’s sera were checked for HBsAg
using an ELISA assay kit (DRG Instruments, Germany).
Anti-HDV antibody was detected in using 3
rd generation
Enzyme ELISA (DIA.PRO, Diagnostic Bioprobes Srl Italy)
kits using the methodology described in the manufac-
turer’s protocol.
HDV RNA extraction and complementary DNA (cDNA)
synthesis
HDV RNA was extracted from 100 μLs e r u ms a m p l e s
using Gentra (Puregene, Minneapolis, MN 55441 USA)
RNA Isolation kit according to the manufacturer’sp r o -
tocol. The extracted RNA (10 μL) was reverse tran-
scribed into cDNA with Moloney Murine Leukemia
Virus (MMLV) reverse transcriptase (Life Technologies
Inc., USA). Briefly, 1 μl of HDV-specific antisense pri-
mer (10 pmol/μl) nucleotides 873-896 {5’-CCGCGAG-
GAGGTGGAGATGCCATG-3’}w a sm i x e dw i t h1 0μL
of extracted RNA followed by incubation at 70°C in
thermal cycler for 10 minutes. Then cooled on ice for 2
minutes and added 9 μL of RT Mix that contained 50
mM Tris-HCl (pH 8.3), 7.5 mM KCl, 3 mM MgCl2,0 . 1
MD T T ,1 0m Md N T P sa n d2 0 0Uo fM M L Vr e v e r s e
transcriptase enzyme. cDNA was synthesized at 37°C for
50 minutes and then heat inactivated the MMLV
Enzyme at 95°C for 3 minutes. Spun down and stored at
-20°C till was used in nested PCR.
Qualitative detection of HDV cDNA
The qualitative detection of HDV-cDNA was carried out
by nested PCR using four μl of synthesized HDV-cDNA.
The first round PCR was done in a tube containing 20
μl of PCR reaction mixture (2.5 mM MgCl2, a 100 μM
concentration of each of the four deoxynucleotides
(dNTPs), 10 pM of each outer sense nucleotides 695-
718 {5’-CATGGTCCCAGCCTCCTCGCTGGC-3’}a n d
outer antisense primers nucleotides 873-896 {5’-
CCGCGAGGAGGTGGAGATGCCATG-3’}[ 1 1 ]a n d1
U of Taq DNA polymerase Enzyme). The thermocycler
(ABI PCR system 2700; PE Applied Biosystem Inc.,
USA) was programmed to initially incubate the samples
for 2 min at 95°C, followed by 35 cycles consisting of
95°C for 1 min, 64°C for 1 min, and 72°C for 1 min.
Second round PCR was performed with the same reac-
tion mix and amplification conditions using inner sense
nucleotides 729-748 (5’-CAACATTCCGAGGGGA
CCGT-3’) and inner antisense primers nucleotides 846-
865 (5’-GAAGGAAGGCCCTCGAGAACAAGA-3’) [11].
Standard precautions to avoid contamination during
PCR were taken. Positive controls (HDV ELISA & PCR
positive) and negative controls (negative HDV serum
and distilled water) were included in each run. Finally
the PCR products were electrophoresed on a 2% agarose
gel prepared in 1× Tris-borate-EDTA (TBE) buffer,
stained with ethidium bromide, and evaluated under UV
transilluminator. The sizes of PCR products were esti-
mated according to the migration pattern of a 50-bp
DNA ladder (Fermentas Life Sciences). The sizes of the
first round PCR products and nested PCR were 202-
base pair (bp) and 137-bp respectively.
Results
The subject disposition and major features of the results
are shown in figure 1. Total 200 samples that were posi-
tive in initial screening in different blood banks were
received from different regions of the Punjab province.
Majority of the samples belonged to males (60.5%) and
the mean age of subjects was 42.5 ± 8.9 years. All these
subjects were found positive by rapid test device (Accu-
rate or SD Diagnostics) and definitive diagnosis of hepa-
titis B virus was required by ELISA method. Complete
history and records of the patients were maintained. For
all the samples HBsAg and anti-HDV ELISAs were
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Page 2 of 5Figure 1 Patients’ Disposition and main features of the study. During the course of this study, total 200 samples positive by HBsAg rapid
test were received from different geographical parts of Punjab province. Out of these, 96 (48%) were found positive by HBsAg ELISA. Of these
HBsAg ELISA positive samples, total 80 (83%) samples were found reactive by anti-HDV ELISA method. Of these HBsAg and anti-HDV positive
samples, 24 (30%) were further found positive by HDV RNA PCR.
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nology, University of the Lahore, Pakistan. While HDV
RNA extraction followed by PCR amplifications for
HDV was conducted at the Division of Molecular Virol-
ogy, National Centre of Excellence in Molecular Biology,
University of the Punjab, Lahore. The data sheets
showed that the infected patients had been involved in
various high risk behaviors such as major minor sur-
geries, re-use of syringes, dental procedures, blood cup-
ping (in males) etc.
Of the total 200 sera samples, 96 (48%) were found
reactive for HBsAg by ELISA method. All the HBsAg
positive samples were subjected to anti-HDV ELISA.
The result of anti-HDV ELISA showed that 80 (88.81%)
out of total 96 subjects were found positive by anti
HDV ELISA assay. Of these 80 anti-HDV positive sub-
jects, 35 were females (43.7%) and 45 were males
(56.3%).
HDV RNA was performed for all 80 anti-HDV ELISA
assay for further confirmation of active HDV infection.
Figure 2 shows a typical agarose gel showing the specific
HDV bands using HDV gene-specific primers in nested
PCR. The PCR results confirmed that total 24 (30%) out
of 80 anti HDV ELISA positive subjects had active HDV
infection in these HBV positive subjects. Of the patients
with mixed HBV & HDV infection, 19 were males and 5
were females.
Discussion
Delta hepatitis is still a major global health problem
affecting 15-20 million individuals world wide. HDV co-
infection or super infection means that the host liver
cells are previously been infected by hepatitis B virus.
HDV co-infection or super infection leads to the cirrho-
sis of the liver and finally hepatocellular carcinoma
(HCC) or liver cancer [3,5,6,12]. The current study
shows an extremely high prevalence of HDV infection
in the province of Punjab Pakistan. Previously it has
been assumed that in the rural areas a high prevalence
o fH D Ve x i s t st h a ti sn o ts u p p o r t e db yo u rs t u d ya s
majority of our subjects were from urban areas that
means that even in cities a high prevalence rates of dual
HDV-HBV infection exists. Though the sample size of
our study is not very large as compared to that of earlier
studies still the results are very interesting and impor-
tant as this is the first study from Punjab on the subject
where a high prevalence rate of HDV-HBV co-infection
has been observed. Importantly we have seen a higher
prevalence rate of HDV infection in young males com-
pared to females. Our observation is supported by the
findings of a previously published epidemiological survey
in Pakistan where the rate of HDV infection was
reported higher in young males compared in females [7].
One of the interesting findings of the current study is
the observation of high positivity rate of anti-HDV
ELISA that is 88.8% in HBV positive patients. This posi-
tivity rate is very high as compared to previously
reported rates from Pakistan by Mumtaz and colleagues
[7], where the reported HDV prevalence rate was 16.6%
and Seetlani et al., [9] who showed an overall HDV pre-
valence of 58.6%. This reported prevalence rate of HDV
by Seetlani and co-workers [9] is much higher than that
reported by Mumtaz et al. [7], however is still much
lower than our findings (about 30%).
The results of this study further suggest that the pre-
valence of HBV/HDV co-infection in Pakistan has
increased during the last decade. On the other hand an
overall decline in the worldwide HDV infection has
been observed globally [13]. This decrease in HDV pre-
valence internationally may be due to worldwide HBV
vaccination and treatment; for this reason HDV infec-
tion is decreased over time along with HBV infection
[9,12,14,15]. Even in India that is our neighbor in the
East, a decline in HDV infection has been seen in recent
years [14]. The same tendency in HDV decline has also
been observed in Turkey [15]. Unfortunately in Pakistan
we have not seen this tendency in the decline of HDV
infection as HBV vaccination programs are not so com-
mon and popular in this country as compared to India
and Turkey. An important question arise over here that
why the prevalence of HDV increase over time? is
unknown to us. More research is needed on the subject
to find out causes for this increase in the prevalence
rate of HDV overtime.
The most interesting finding of the current study is
the observation that the rate of active HDV infection is
just 30% in Pakistan as was declared by positive qualita-
tive HDV RNA PCR that is still a high rate. Further-
more the prevalence of HDV infection in our PCR study
shows that males are more often infected than females.
This high rate of HDV infection in males is attributed
Figure 2 Gel photograph of different HDV product. Lane 1:
showing no HDV specific band and are thus HDV negative; Lane 2:
50-bp DNA Ladder marker; Lanes 3-5: showing HDV positive
samples (137-bp); Lane 6 showing negative control (showing no
HDV specific band); Lane 7 is positive control showing 137-bp HDV
specific band.
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authorities, practitioners and health care managers
should be made aware of the risk factors associated with
dual infection of HBV and HDV. Proper vaccination
and awareness programs should be started to prevent
this HBV/HDV dual coinfection.
Our study has few limitations. For example, the sam-
ple size is small as only 200 HBsAg positive sera sam-
ples by rapid test devices were included in the current
study that cannot represent the entire population of
Punjab. Next, the information about risk factors was
collected from a questionnaire that may vary in comple-
teness and be more exposed to prejudice.
Conclusion
The results of the current study show a high prevalence
rate of HDV-HBV co-infection in Pakistan that has been
increased over time. Pakistan is an endemic country for
HDV infection. Males are more infected than females.
Ministry of health should pay attention to the risk fac-
tors responsible for the spread of this dual HDV/HBV
infection.
Abbreviations
HDV: hepatitis delta virus; HBV: hepatitis B virus; HCC: hepatocellular
carcinoma; HBSAG: hepatitis B surface antigen; ELISA: enzyme linked
immunosorbent assay; CDNA: complementary DNA; RNA: ribonucleic acid;
M-MLV RTase: Moloney Murine Leukemia Virus reverse transcriptase; ABI:
Applied Biosystems Inc.; PCR: polymerase chain reaction. TBE: tris-boric acid-
EDTA; UV: ultraviolet.
Acknowledgements
The authors thank all the subjects and doctors for their cooperation in the
study.
Author details
1Department of Biotechnology, University of The Lahore, 1-KM Raiwind Road,
Lahore, Pakistan.
2Division of Molecular Virology, National Centre of
Excellence in Molecular Biology, University of the Punjab 87-West Canal Bank
Road Thokar Niaz Baig, Lahore, Pakistan.
3Department of Pathology,
Independent Medical College, Faisalabad, Pakistan.
Authors’ contributions
RH, GZ and MI conceived of the study participated in its design and
coordination and gave a critical view of manuscript writing. GZ collected
samples, epidemiological data, perform all the serological and molecular
biology assays and analyzed the data statistically. MI, FAM, ZA, IM, MS SY, AT
and RH participated in data analysis. All the authors read and approved the
final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 September 2010 Accepted: 26 October 2010
Published: 26 October 2010
References
1. Cramer DA: Hepatitis D. Gale Encyclopedia of Medicine (the Gale Group)
2002.
2. Taylor JM: Replication of human hepatitis Delta virus: Recent
developments. Trends Microbial. 2003, 11:185-190.
3. Gupta P, Biswas D, Shukla I, Bal A: Need for Routine Screening of HBV and
HDV in Patients with Cirrhosis of the Liver. Ind J Med Microbiol 2005,
23:141-142.
4. Sheldon J, Ramos B, Toro C, Rios P, Martinez J, Alarcon Bottecchia M: Does
treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus
HDV replication in HIV-HBV-HDV Coinfection patients? Antivir Ther 2008,
13:97-102.
5. Carmo-Fonseca JC: Hepatitis D. Rev Soc Bras Med Trop 2002, 35:191-90.
6. Rizzetto M, Hoyer B, Canese MG, Pureell RH, Gerin JL: Delta agent
association of Delta antigen with hepatitis B surface antigen and RNA in
serum of Delta infected chimpanzees. Proc Natt Acad Sci USA 1989,
77:6124-6128.
7. Mumtaz K, Hamid SS, Adil S, Afaq A, Islam M, Abid S: Epidemiology and
clinical pattern of hepatitis delta virus infection in Pakistan. J
Gastroenterol Hepatol 2005, 20:1503-7.
8. Qureshi H, Ambreen A, Ejaz A: Treatment of HBV and HDV co-infection
using Lamivudine. J Ayub Med Coll Abbottabad 2009, 21:1-3.
9. Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafri W: Prevalence of Hepatitis D
in HBsAg positive patients visiting liver clinics. JPMA 2009, 59:434.
10. Zuberi BF, Salahuddin A, Quraishy MS: Triple hepatitis: frequency and
treatment outcome of co/super infection of hepatitis C and D among
patient of hepatitis B. J Coll Physicians Surg Pak 2008, 18:404-407.
11. Makino S, Change MF, Sheikh CK, Kamahora T, Vannier DM, Govindarejin S:
Molecular cloning and sequencing of a human delta virus RNA. Nature
1987, 329:343-346.
12. Hsieh TH, Liu CJ, Chen DS, Chen PJ: Natural course and treatment of
hepatitis D virus infection. J Formos Med Assoc 2006, 105:869-81.
13. Al-Traif A, Dafalla M, Al-Tamimi M, Qassem L: Prevalence of hepatitis delta
among HBsAG Carriers in Saudi Arabid. Ann Saudi Med 2004, 24:343-4.
14. Chakraborty P, Kailash U, Jain A, Goyal R, Gupta RK, Das BC: Seroprevalence
of hepatitis D virus in patients with hepatitis B virus-related liver
diseases. Indian J Med Res 2005, 122:254-7.
15. Deertekin H, Yalçin K, Yakut M: The prevalence of hepatitis delta virus
infection in acute and chronic liver diseases in Turkey: an analysis of
clinical studies. Turk J Gastroenterol 2006, 17:25-34.
doi:10.1186/1743-422X-7-283
Cite this article as: Zaidi et al.: Prevalence of hepatitis delta virus
infection among hepatitis b virus surface antigen positive patients
circulating in the largest province of pakistan. Virology Journal 2010
7:283.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zaidi et al. Virology Journal 2010, 7:283
http://www.virologyj.com/content/7/1/283
Page 5 of 5